Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection
- PMID: 19254880
- DOI: 10.1016/j.autrev.2009.01.017
Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection
Abstract
It has been noted since 1981 that late primary infection with the Epstein-Barr virus (EBV) in adolescence or young adulthood can account for the epidemiology of multiple sclerosis (MS), including the association with higher socio-economic status, the latitudinal variation in prevalence, the effects of migration on the risk of acquiring MS, and the occurrence of clusters and epidemics. Virtually all (>99%) people with MS are EBV seropositive, suggesting that EBV infection is essential for the development of MS. The EBV-infected autoreactive B-cell hypothesis of autoimmunity published in 2003 proposes that, in genetically susceptible individuals, EBV-infected autoreactive B cells seed the target organ where they produce pathogenic autoantibodies and provide costimulatory survival signals to autoreactive T cells. This hypothesis makes several predictions, some of which have been verified in the case of MS, namely: the presence of EBV-infected B cells in the central nervous system; a beneficial response to B-cell depletion with rituximab; and decreased CD8(+) T-cell immunity to EBV-infected B cells. The hypothesis also predicts that chronic autoimmune diseases will respond to treatment which controls EBV infection. Thus it is proposed that vaccination against EBV will prevent MS, and that effective antiviral drugs will inhibit disease progression in people with MS and potentially be curative.
Similar articles
-
Epstein-Barr virus and multiple sclerosis.J Neurol Sci. 2009 Nov 15;286(1-2):62-4. doi: 10.1016/j.jns.2009.03.028. Epub 2009 Apr 10. J Neurol Sci. 2009. PMID: 19361810 Review.
-
Autoimmune disease: A role for new anti-viral therapies?Autoimmun Rev. 2011 Dec;11(2):88-97. doi: 10.1016/j.autrev.2011.08.005. Epub 2011 Aug 18. Autoimmun Rev. 2011. PMID: 21871974 Review.
-
Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis.Med Hypotheses. 2008;70(1):66-9. doi: 10.1016/j.mehy.2007.04.030. Epub 2007 Jun 14. Med Hypotheses. 2008. PMID: 17574770
-
Multiple sclerosis is linked to Epstein-Barr virus infection.Rev Med Virol. 2006 Sep-Oct;16(5):297-310. doi: 10.1002/rmv.503. Rev Med Virol. 2006. PMID: 16927411 Review.
-
EBV in MS: guilty by association?Trends Immunol. 2009 Jun;30(6):243-8. doi: 10.1016/j.it.2009.03.007. Epub 2009 May 8. Trends Immunol. 2009. PMID: 19428300
Cited by
-
Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.Cell Mol Immunol. 2021 May;18(5):1122-1140. doi: 10.1038/s41423-020-00626-z. Epub 2021 Apr 1. Cell Mol Immunol. 2021. PMID: 33795850 Free PMC article. Review.
-
Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.J Immunol. 2010 Aug 1;185(3):1949-58. doi: 10.4049/jimmunol.1001159. Epub 2010 Jun 30. J Immunol. 2010. PMID: 20592286 Free PMC article.
-
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.Front Immunol. 2021 Nov 15;12:656797. doi: 10.3389/fimmu.2021.656797. eCollection 2021. Front Immunol. 2021. PMID: 34867935 Free PMC article. Review.
-
Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells.PLoS One. 2013 Jul 22;8(7):e69827. doi: 10.1371/journal.pone.0069827. Print 2013. PLoS One. 2013. PMID: 23894549 Free PMC article.
-
The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.Eur J Microbiol Immunol (Bp). 2011 Dec;1(4):267-78. doi: 10.1556/EuJMI.1.2011.4.2. Epub 2011 Dec 23. Eur J Microbiol Immunol (Bp). 2011. PMID: 24516733 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials